30 /100
MEDIUM RISK
Score updated May 30, 2026

LYRA — Lyra Therapeutics, Inc. Dilution Risk Tracker

Track LYRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LYRA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
80
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.65 below $1 exchange minimum
🔔 Track LYRA — Get forecast alerts →

💹 Market Data

Market Cap$1.24M
Shares Outstanding1.77M
Float336.1K
Cash$15.89M
Debt$30.26M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 46.0% shares (2025Q4 vs prior)
24 institutional holders · 242.7K shares
#1 SABBY MANAGEMENT, LLC 175.2K shares
#2 Ikarian Capital, LLC 21.2K shares
#3 DRW Securities, LLC 16.8K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.2K
Days to Cover1.0
% of Float0.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track LYRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LYRA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for LYRA
📊 LYRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LYRA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.